Summary of Study ST001420

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000974. The data can be accessed directly via it's Project DOI: 10.21228/M8SQ55 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)
Study IDST001420
Study TitleMetabolomic analysis of patients with recurrent angina
Study TypeCase and control studies
Study SummaryThis is a prospective study. After an overnight fast, venous blood was collected from patients with PCI. The patients were discharged after the blood draw. They were followed up every 30 days for angina recurrence up to 270 days (9 months). The samples were grouped into two groups: recurrent angina and angina-free based on the follow-up results at 9 months.
Institute
University of California, San Diego
Last NameCui
First NameSong
Address9500 Gilman Drive, San Diego, CA, 92093, USA
Emailkli@ucsd.edu
Phone8582304220
Submit Date2020-06-30
Num Groups2
Total Subjects750
Num Males365
Num Females385
Release Date2020-07-30
Release Version1
Song Cui Song Cui
https://dx.doi.org/10.21228/M8SQ55
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Subject:

Subject ID:SU001494
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Age Or Age Range:59 ± 14.6
Gender:Male and female
Human Ethnicity:Asian
Human Medications:All with aspirin and clopidogrel
Human Smoking Status:22.2% were smokers
Human Inclusion Criteria:The inclusion criteria were hospitalized CAD patients with stable angina.
Human Exclusion Criteria:Patient with the lesion of > 90% stenosis or total occlusion, active inflammation (High sensitive C-reactive protein [hsCRP] >1.0 mg/dl), renal disease (serum creatinine > 3.0 mg/dl or ongoing hemodialysis), the onset of cancer in the previous five years, coronary artery bypass grafting, contraindications to iodine media, and severe hepatic insufficiency.
  logo